Sma

1 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business

Roche has halted the development of emugrobart, a muscle-preserving obesity drug candidate, following a failed interim analysis.

5 sources 5 articles v 3 2h ago

\n \n \n

\n \n \n \n